Overview

Haloperidol vs Conventional Therapy for Gastroparesis

Status:
Terminated
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Randomized controlled trial comparing haloperidol combined with conventional therapy and conventional therapy alone in patients with symptomatic gastroparesis.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Treatments:
Haloperidol
Haloperidol decanoate